1. Antibody-drug Conjugate/ADC Related Metabolic Enzyme/Protease
  2. Radionuclide-Drug Conjugates (RDCs) Ser/Thr Protease
  3. 102849-12-7

102849-12-7

3-(N-Maleimidopropionyl)biocytin Chemical Structure

102849-12-7

Chemical Structure

  • 3-(N-Maleimidopropionyl)biocytin
  • CAS No: 102849-12-7
    Formula: C23H33N5O7S
    Molecular Weight: 523.60
  • IUPAC Name: N2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl)-N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-L-lysine
  • InChIKey: KWNGAZCDAJSVLC-OSAWLIQMSA-N
  • SMILES: O=C(C=CC1=O)N1CCC(N[C@H](C(O)=O)CCCCNC(CCCC[C@H]2[C@]3([H])[C@](NC(N3)=O)([H])CS2)=O)=O

Biological Activity: 3-(N-Maleimidopropionyl)biocytin is a membrane impermeable biocytin that can be used for mitochondrial structure research[1].

Cat. No. Product Name Purity Description
HY-106841 Draflazine 99.06% Draflazine (R-75231) is a ENT1 inhibitor. Draflazine (R-75231) completely reverses the hypersensitivity in the complete Freund’s adjuvant (CFA) model of mechanical hyperalgesia and the carrageenan inflammation model of thermal and mechanical hyperalgesia.

References